# ATOS (Atossa Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Atossa Therapeutics, Inc. reported $26.45M in total assets and a net loss of $34.66M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ATOS
- Markdown: https://convexityos.com/fundamentals/ATOS.md
- SEC CIK: 0001488039
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:03 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001488039&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$35.90M | Operating profit |
| Net Income | FY 2025 | -$34.66M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$3.47 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$35.29M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $20.57M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $21.18M | $14.12M | $17.33M | $15.08M | $9.21M | $6.61M | $6.65M | $4.21M | $2.33M | $770K |
| Total Operating Expenses | $37.14M | $27.62M | $31.38M | $27.69M | $20.52M | $14.61M | $17.27M | $11.43M | $7.65M | $7.97M |
| **Operating Income** | -$37.14M | -$27.62M | -$31.38M | -$27.69M | -$20.52M | -$14.61M | -$17.27M | -$11.43M | -$7.65M | -$7.97M |
| **EBITDA** | -$37.12M | -$27.60M | -$31.35M | -$27.68M | -$20.50M | -$14.56M | -$17.21M | -$11.39M | -$7.52M | -$7.67M |
| Interest Income | $2.38M | $4.05M | $4.34M | $877K | $6.0K | -- | -- | -- | -- | -- |
| Income Before Tax | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.40M | -$8.12M | -$6.37M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -- |
| **Net Income** | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.40M | -$8.12M | -$6.37M |
| Basic EPS | -$4.04 | -$3.04 | -$3.60 | -$3.15 | -$2.70 | -$29.55 | -$30.45 | -$82.50 | -$164.55 | -$32.40 |
| **Diluted EPS** | -$4.04 | -$3.04 | -$3.60 | -$3.15 | -$2.70 | -$29.55 | -$30.45 | -$82.50 | -$164.55 | -$32.40 |
| Basic Shares Outstanding | 8.6M | 8.4M | 8.4M | 8.4M | 7.8M | 754 | 566.5K | 277.2K | 65.0K | 196.5K |
| Diluted Shares Outstanding | 8.6M | 8.4M | 8.4M | 8.4M | 7.8K | 754 | 566.5K | 277.2K | 65.0K | 196.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $3.38M | $4.90M | $4.78M | $6.16M | $5.37M | $5.50M | $4.16M | $3.40M |
| Total Operating Expenses | $5.90M | $8.69M | $9.87M | $11.44M | $9.25M | $9.04M | $7.41M | $7.15M |
| **Operating Income** | -$5.90M | -$8.69M | -$9.87M | -$11.44M | -$9.25M | -$9.04M | -$7.41M | -$7.15M |
| **EBITDA** | -$5.89M | -$8.69M | -$9.87M | -$11.43M | -$9.25M | -$9.04M | -$7.41M | -$7.15M |
| Interest Income | $209K | $227K | $309K | $442K | $570K | $645K | $720K | $837K |
| Income Before Tax | -$5.64M | -$8.49M | -$9.59M | -$10.94M | -$8.69M | -$8.42M | -$6.72M | -$6.35M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$5.64M | -$8.49M | -$9.59M | -$10.94M | -$8.69M | -$8.42M | -$6.72M | -$6.35M |
| Basic EPS | -$0.56 | -$0.95 | -$1.11 | -- | -$1.01 | -$0.98 | -$0.78 | -- |
| **Diluted EPS** | -$0.56 | -$0.95 | -$1.11 | -- | -$1.01 | -$0.98 | -$0.78 | -- |
| Basic Shares Outstanding | 10.0M | 8.9M | 8.6M | -- | 8.6M | 8.6M | 8.6M | -- |
| Diluted Shares Outstanding | 10.0M | 8.9M | 8.6M | -- | 8.6M | 8.6M | 8.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $41.30M | $71.08M | $88.46M | $110.9M | $136.4M | $39.55M | $12.58M | $10.38M | $7.22M | $3.03M |
| **Cash & Short-Term Investments** | $41.30M | $71.08M | $88.46M | $110.9M | $136.4M | $39.55M | $12.58M | $10.38M | $7.22M | $3.03M |
| Other Current Assets | -- | -- | -- | $2.42M | $1.19M | $657K | $26K | $31K | $16K | -- |
| **Total Current Assets** | $45.62M | $74.46M | $92.22M | $118.2M | $141.2M | $42.77M | $14.32M | $11.55M | $7.90M | $3.25M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $20K | $21K | $34K | $54K | $11K | $55K |
| Intangible Assets | -- | -- | -- | -- | $54K | $41K | $174K | $192K | $234K | $640K |
| Other Non-Current Assets | $1.99M | $1.99M | $2.32M | $635K | $22K | $17K | $17K | $17K | $179K | $194K |
| **Total Non-Current Assets** | $1.99M | $1.99M | $4.03M | $5.33M | $22K | $69K | $171K | $171K | $266K | $890K |
| **Total Assets** | $47.61M | $76.44M | $96.25M | $123.5M | $141.3M | $42.84M | $14.49M | $11.72M | $8.16M | $4.14M |
| Accounts Payable | $4.29M | $679K | $806K | $2.96M | $1.72M | $1.59M | $293K | $353K | $335K | $254K |
| Other Current Liabilities | $1.10M | $1.51M | $1.80M | $19K | $21K | $4.0K | $13K | $40K | $16K | $6.1K |
| **Total Current Liabilities** | $8.26M | $4.97M | $5.24M | $5.57M | $3.13M | $15.67M | $1.32M | $2.92M | $1.23M | $1.05M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $11K | $0 | $0 | $0 |
| **Total Liabilities** | $8.26M | $4.97M | $5.24M | $5.57M | $3.13M | $15.67M | $1.33M | $2.92M | $1.23M | $1.05M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $18K | $50K | -- | -- | -- |
| Common Stock | $1.55M | $1.55M | $22.79M | $22.79M | $22.79M | $8.56M | $1.64M | $1.05M | $477K | $57K |
| Retained Earnings | -$246.6M | -$211.8M | -$186.3M | -$156.2M | -$129.2M | -$111.9M | -$94.07M | -$76.83M | -$65.43M | -$57.30M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $39.35M | $71.48M | $91.02M | $118.0M | $138.1M | $27.17M | $13.16M | $8.81M | $6.94M | $3.10M |
| Total Equity | $39.35M | $71.48M | $91.02M | $118.0M | $138.1M | $27.17M | $13.16M | $8.81M | $6.94M | $3.10M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.57M | $26.09M | $31.72M | $41.30M | $51.84M | $57.86M | $65.12M | $71.08M |
| **Cash & Short-Term Investments** | $20.57M | $26.09M | $31.72M | $41.30M | $51.84M | $57.86M | $65.12M | $71.08M |
| **Total Current Assets** | $25.18M | $31.01M | $36.67M | $45.62M | $55.68M | $62.52M | $68.74M | $74.46M |
| Other Non-Current Assets | $1.27M | $1.27M | $1.27M | $1.99M | $2.33M | $2.00M | $2.00M | $1.99M |
| **Total Non-Current Assets** | $1.27M | $1.27M | $1.27M | $1.99M | $2.33M | $2.00M | $2.00M | $1.99M |
| **Total Assets** | $26.45M | $32.28M | $37.94M | $47.61M | $58.01M | $64.52M | $70.75M | $76.44M |
| Accounts Payable | $1.50M | $1.98M | $2.57M | $4.29M | $3.54M | $2.01M | $1.17M | $679K |
| Other Current Liabilities | $745K | $1.12M | $1.14M | $1.10M | $1.57M | $1.56M | $1.53M | $1.51M |
| **Total Current Liabilities** | $4.71M | $5.45M | $7.46M | $8.26M | $8.22M | $6.82M | $5.42M | $4.97M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $4.71M | $5.45M | $7.46M | $8.26M | $8.22M | $6.82M | $5.42M | $4.97M |
| Common Stock | $1.80M | $1.80M | $1.55M | $1.55M | $23.49M | $23.49M | $23.49M | $1.55M |
| Retained Earnings | -$270.3M | -$264.6M | -$256.2M | -$246.6M | -$235.6M | -$226.9M | -$218.5M | -$211.8M |
| **Total Stockholders' Equity** | $21.74M | $26.83M | $30.49M | $39.35M | $49.79M | $57.70M | $65.32M | $71.48M |
| Total Equity | $21.74M | $26.83M | $30.49M | $39.35M | $49.79M | $57.70M | $65.32M | $71.48M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$34.77M | -$25.50M | -$30.09M | -$26.96M | -$20.61M | -$17.83M | -$17.24M | -$11.40M | -$8.12M | -$6.37M |
| Depreciation & Amortization | $16K | $17K | $23K | $8.0K | $23K | $47K | $53K | $44K | $129K | $303K |
| Stock-Based Compensation | $2.65M | $2.29M | $4.62M | $6.79M | $5.27M | $3.02M | $7.10M | $1.05M | $787K | $876K |
| Change in Payables | $3.61M | -$127K | -$2.16M | $1.25M | $128K | $1.29M | -$60K | $18K | $81K | -$560K |
| **Operating Cash Flow** | -$29.76M | -$21.03M | -$20.94M | -$20.76M | -$16.47M | -$11.57M | -$9.13M | -$8.96M | -$6.59M | -$5.37M |
| Capital Expenditure | -$23K | -$19K | -$14K | -$27K | -$9.0K | -$9.0K | -$7.6K | -$111K | -- | -- |
| **Free Cash Flow** | -$29.79M | -$21.05M | -$20.95M | -$20.79M | -$16.48M | -$11.58M | -$9.14M | -$9.07M | -- | -- |
| **Investing Cash Flow** | -$23K | -$19K | -$14K | -$4.73M | -$9.0K | -$9.0K | -$7.6K | -$111K | -- | -$9.2K |
| Common Stock Issued | -- | -- | -- | -- | $113.5M | -- | -- | -- | $6.16M | $4.70M |
| Share Repurchases | -- | $0 | -$1.48M | $0 | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $0 | $3.67M | -$1.48M | $0 | $113.3M | $38.55M | $11.34M | $12.29M | $10.78M | $4.70M |
| **Net Change in Cash** | -$29.79M | -$17.38M | -$22.43M | -$25.49M | $96.82M | $26.97M | $2.20M | $3.22M | $4.19M | -$688K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$5.64M | -$8.49M | -$9.59M | -$10.94M | -$8.69M | -$8.42M | -$6.72M | -$6.35M |
| Depreciation & Amortization | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K |
| Stock-Based Compensation | $547K | $815K | $722K | $503K | $784K | $796K | $563K | $774K |
| Change in Payables | -$475K | -$593K | -$1.72M | $761K | $1.52M | $845K | $486K | -$882K |
| **Operating Cash Flow** | -$5.52M | -$9.64M | -$9.58M | -$10.54M | -$6.00M | -$7.26M | -$5.96M | -$7.05M |
| Capital Expenditure | $0 | $0 | $0 | -$7.0K | -$7.0K | $0 | -$9.0K | $0 |
| **Free Cash Flow** | -$5.52M | -$9.64M | -$9.58M | -$10.55M | -$6.01M | -$7.26M | -$5.97M | -$7.05M |
| **Investing Cash Flow** | $0 | $0 | $0 | -$7.0K | -$7.0K | $0 | -$9.0K | $0 |
| **Financing Cash Flow** | $0 | $4.02M | $0 | $0 | $0 | $0 | $0 | $3.37M |
| **Net Change in Cash** | -$5.52M | -$5.62M | -$9.58M | -$10.55M | -$6.01M | -$7.26M | -$5.97M | -$3.68M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -88.4% | -35.7% | -33.1% | -22.9% | -14.9% | -65.6% | -131.0% | -129.5% | -117.1% | -205.6% |
| Return on Assets (ROA) | -73.0% | -33.4% | -31.3% | -21.8% | -14.6% | -41.6% | -119.0% | -97.3% | -99.5% | -153.7% |
| Current Ratio | 5.53x | 14.99x | 17.61x | 21.23x | 45.18x | 2.73x | 10.83x | 3.96x | 6.45x | 3.11x |
| Quick Ratio | 5.00x | 14.31x | 16.89x | 19.92x | 43.63x | 2.52x | 9.51x | 3.56x | 5.89x | 2.89x |
| Debt to Equity | -- | -- | -- | -- | -- | 0.00x | 0.00x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -159.4% | -140.5% | -123.5% | -88.4% | -60.6% | -49.8% | -40.3% | -35.7% |
| Return on Assets (ROA) | -131.0% | -116.8% | -99.2% | -73.0% | -52.0% | -44.5% | -37.2% | -33.4% |
| Current Ratio | 5.35x | 5.69x | 4.92x | 5.53x | 6.77x | 9.17x | 12.67x | 14.99x |
| Quick Ratio | 4.37x | 4.79x | 4.25x | 5.00x | 6.30x | 8.48x | 12.00x | 14.31x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
